Stay current with the latest sickle cell research, regulatory updates, and guidelines.
To investigate cerebral microvascular injury in a humanized mouse model of sickle cell disease (SCD) and examine the relationship between cerebral microhemorrhages (CMHs) and mast cells.
To evaluate digital cognitive behavioral therapy (CBT) versus usual care for reducing pain intensity and pain interference among adolescents and young adults with sickle cell disease (SCD), and to compare...
To describe the use of kyphoplasty for management of vertebral compression fractures and chronic spinal pain in a patient with sickle cell disease (SCD)–associated osteonecrotic spinal pathology.
To evaluate the prevalence of psychosocial neglect and patterns of under-recognized psychosis among young adults with sickle cell disease (SCD) and to examine their impact on treatment, pain reduction, and...
To evaluate whether implementation of a standardized electronic medical record (EMR) admission order set could improve hospitalization outcomes for patients admitted with sickle cell pain crisis.
To investigate whether vaso-occlusive episodes (VOE) and other clinical factors influence variability in urine albumin-to-creatinine ratio (UACR) in patients with sickle cell disease (SCD).
To describe clinical presentation, diagnostic challenges, and management of fat embolism syndrome (FES) in adolescents with sickle cell disease (SCD).
To evaluate whether a biologicmarker — flow adhesion of whole blood to P-selectin (FA-WB-PSEL) — correlates with clinical outcomes inpatients with sickle cell disease treated with crizanlizumab.
To investigate whether alterations in resting-state functional connectivity are associated with pain sensitivity and cognitive changes in sickle cell disease (SCD).
To assess whether non-myeloablative hematopoietic cell transplantation can affect the progression of multi-organ damage in a preclinical sickle cell disease model.